MBBS · Pharmacology

Unit 2: Autonomic Pharmacology MCQs

55 solved multiple choice questions with answers and short explanations.

Q1. Acetylcholine is synthesized in cholinergic nerve terminals from choline and acetyl-CoA by:

  1. ACholine acetyltransferase
  2. BAcetylcholinesterase
  3. CTyrosine hydroxylase
  4. DMonoamine oxidase
Show answer
Answer: A. Choline acetyltransferaseCholine acetyltransferase catalyzes formation of acetylcholine from choline and acetyl-CoA in the cytoplasm of cholinergic neurons.
Report a mistake

Q2. The principal mechanism terminating acetylcholine action in a synaptic cleft is:

  1. AReuptake of intact acetylcholine
  2. BHydrolysis by acetylcholinesterase
  3. CMetabolism by COMT
  4. DDiffusion into erythrocytes only
Show answer
Answer: B. Hydrolysis by acetylcholinesteraseAcetylcholinesterase rapidly hydrolyzes acetylcholine into acetate and choline, terminating its synaptic action.
Report a mistake

Q3. Activation of cardiac M2 receptors most directly causes:

  1. APupillary dilation
  2. BBronchodilation
  3. CReduced heart rate
  4. DIncreased renin release
Show answer
Answer: C. Reduced heart rateM2 receptor activation increases potassium conductance and decreases cAMP in cardiac pacemaker tissue, slowing heart rate.
Report a mistake

Q4. M3 receptor activation in bronchial smooth muscle tends to produce:

  1. ASkeletal muscle paralysis
  2. BBronchodilation
  3. CTachycardia
  4. DBronchoconstriction
Show answer
Answer: D. BronchoconstrictionM3 receptors couple to Gq signaling and increase intracellular calcium, causing bronchial smooth-muscle contraction.
Report a mistake

Q5. Stimulation of M3 receptors in exocrine glands generally increases:

  1. ASecretions
  2. BRenin release
  3. CHeart rate
  4. DSkeletal muscle tone
Show answer
Answer: A. SecretionsMuscarinic M3 activation promotes salivary, lacrimal, bronchial, and other glandular secretions.
Report a mistake

Q6. Nicotinic Nm receptors are located primarily at the:

  1. ASA node
  2. BNeuromuscular junction
  3. CBronchial smooth muscle
  4. DSweat gland effector junction
Show answer
Answer: B. Neuromuscular junctionNm nicotinic receptors are ligand-gated ion channels on skeletal muscle end plates at the neuromuscular junction.
Report a mistake

Q7. Nicotinic Nn receptors are found in autonomic ganglia and the:

  1. AVentricular myocardium only
  2. BSkeletal muscle end plate only
  3. CAdrenal medulla
  4. DRenal collecting duct
Show answer
Answer: C. Adrenal medullaNeuronal nicotinic receptors mediate transmission in autonomic ganglia and stimulate catecholamine release from adrenal chromaffin cells.
Report a mistake

Q8. Bethanechol is useful for selected patients with urinary retention because it stimulates:

  1. ANicotinic Nm receptors only
  2. BBeta-2 receptors
  3. CAlpha-1 receptors
  4. DMuscarinic receptors
Show answer
Answer: D. Muscarinic receptorsBethanechol is a direct muscarinic agonist that increases detrusor contraction and promotes bladder emptying.
Report a mistake

Q9. Pilocarpine can increase salivary secretion and lower intraocular pressure through activation of:

  1. AMuscarinic receptors
  2. BAlpha-2 receptors
  3. CBeta-1 receptors
  4. DDopamine D2 receptors
Show answer
Answer: A. Muscarinic receptorsPilocarpine is a muscarinic agonist that promotes glandular secretion and contracts the ciliary muscle, facilitating aqueous outflow.
Report a mistake

Q10. Methacholine is used diagnostically because inhalation can provoke bronchoconstriction in patients with airway:

  1. AFibrosis only
  2. BHyperresponsiveness
  3. CPulmonary embolism
  4. DPleural effusion
Show answer
Answer: B. HyperresponsivenessMethacholine is a muscarinic agonist used in bronchial challenge testing to demonstrate airway hyperreactivity.
Report a mistake

Q11. Neostigmine increases acetylcholine at cholinergic synapses by inhibiting:

  1. AMonoamine oxidase
  2. BCholine acetyltransferase
  3. CAcetylcholinesterase
  4. DCatechol-O-methyltransferase
Show answer
Answer: C. AcetylcholinesteraseNeostigmine reversibly inhibits acetylcholinesterase, increasing acetylcholine at muscarinic and nicotinic synapses.
Report a mistake

Q12. Pyridostigmine improves strength in myasthenia gravis primarily by increasing acetylcholine at the:

  1. ACNS dopamine synapse
  2. BAdrenal cortex
  3. CSA node only
  4. DNeuromuscular junction
Show answer
Answer: D. Neuromuscular junctionBy inhibiting acetylcholinesterase, pyridostigmine increases acetylcholine available to stimulate remaining nicotinic receptors at skeletal muscle end plates.
Report a mistake

Q13. Physostigmine differs from neostigmine because physostigmine can readily enter the:

  1. ACentral nervous system
  2. BRenal tubule only
  3. CSkeletal muscle cell nucleus
  4. DBone marrow only
Show answer
Answer: A. Central nervous systemPhysostigmine is a tertiary amine that crosses the blood-brain barrier, unlike quaternary agents such as neostigmine.
Report a mistake

Q14. Organophosphate poisoning causes excessive cholinergic activity by:

  1. ABlocking muscarinic receptors
  2. BIrreversibly inhibiting acetylcholinesterase
  3. CDepleting acetylcholine vesicles
  4. DStimulating beta-2 receptors
Show answer
Answer: B. Irreversibly inhibiting acetylcholinesteraseOrganophosphates phosphorylate acetylcholinesterase and can produce prolonged enzyme inhibition, causing muscarinic, nicotinic, and CNS toxicity.
Report a mistake

Q15. Atropine is used in organophosphate poisoning primarily to block excessive:

  1. AAcetylcholine synthesis
  2. BNicotinic receptor paralysis directly
  3. CMuscarinic effects
  4. DOrganophosphate absorption only
Show answer
Answer: C. Muscarinic effectsAtropine competitively blocks muscarinic receptors and treats bronchorrhea, bronchospasm, bradycardia, and other muscarinic manifestations.
Report a mistake

Q16. Pralidoxime is most effective in organophosphate poisoning when given before the phosphorylated enzyme undergoes:

  1. AGlucuronidation
  2. BHydrolysis
  3. CAcetylation
  4. DAging
Show answer
Answer: D. AgingPralidoxime can reactivate phosphorylated acetylcholinesterase if administered before aging strengthens the organophosphate-enzyme bond.
Report a mistake

Q17. Atropine commonly causes which effect?

  1. AMydriasis
  2. BMiosis
  3. CBronchorrhea
  4. DDiarrhea
Show answer
Answer: A. MydriasisMuscarinic blockade relaxes the iris sphincter, producing pupillary dilation and cycloplegia.
Report a mistake

Q18. A common adverse effect of systemic antimuscarinic therapy is:

  1. AExcess salivation
  2. BDry mouth
  3. CDiarrhea
  4. DBronchorrhea
Show answer
Answer: B. Dry mouthMuscarinic blockade decreases salivary and other exocrine secretions, commonly causing dry mouth.
Report a mistake

Q19. Atropine can increase heart rate by blocking vagal muscarinic receptors in the:

  1. ASkeletal muscle
  2. BAdrenal cortex
  3. CSA node
  4. DRenal glomerulus
Show answer
Answer: C. SA nodeParasympathetic vagal tone slows the SA node through M2 receptors; atropine removes this restraint and can cause tachycardia.
Report a mistake

Q20. Ipratropium and tiotropium improve airflow in obstructive lung disease primarily by causing:

  1. ARespiratory muscle paralysis
  2. BBronchoconstriction
  3. CPulmonary vasoconstriction
  4. DBronchodilation
Show answer
Answer: D. BronchodilationInhaled muscarinic antagonists reduce vagally mediated bronchial smooth-muscle contraction and decrease bronchoconstriction.
Report a mistake

Q21. Oxybutynin can reduce urinary urgency by blocking muscarinic receptors in the:

  1. ABladder detrusor muscle
  2. BRenal glomerulus
  3. CProstate gland only
  4. DUrethral skeletal muscle
Show answer
Answer: A. Bladder detrusor muscleAntimuscarinic action relaxes detrusor smooth muscle and can reduce symptoms of overactive bladder.
Report a mistake

Q22. Nondepolarizing neuromuscular blockers cause skeletal muscle paralysis by competitively blocking:

  1. AMuscarinic M2 receptors
  2. BNicotinic Nm receptors
  3. CAlpha-1 receptors
  4. DBeta-2 receptors
Show answer
Answer: B. Nicotinic Nm receptorsAgents such as rocuronium competitively antagonize acetylcholine at Nm receptors on the motor end plate.
Report a mistake

Q23. The neuromuscular blockade produced by many nondepolarizing agents can be reversed by increasing acetylcholine with an:

  1. ABeta agonist
  2. BAlpha blocker
  3. CAcetylcholinesterase inhibitor
  4. DMuscarinic agonist only
Show answer
Answer: C. Acetylcholinesterase inhibitorAcetylcholinesterase inhibition raises acetylcholine at the end plate, allowing it to compete with nondepolarizing blockers.
Report a mistake

Q24. Succinylcholine initially causes muscle fasciculations because it acts as a persistent:

  1. ABeta blocker
  2. BMuscarinic antagonist
  3. CAlpha-2 agonist
  4. DNicotinic receptor agonist
Show answer
Answer: D. Nicotinic receptor agonistSuccinylcholine depolarizes Nm receptors, producing brief fasciculations before sustained depolarization prevents further neuromuscular transmission.
Report a mistake

Q25. A potentially life-threatening adverse reaction associated with succinylcholine and volatile anesthetics is:

  1. AMalignant hyperthermia
  2. BSerotonin syndrome
  3. CTorsades de pointes only
  4. DAplastic anemia
Show answer
Answer: A. Malignant hyperthermiaSusceptible patients can develop uncontrolled calcium release, muscle rigidity, hypermetabolism, and hyperthermia; dantrolene is used for treatment.
Report a mistake

Q26. Succinylcholine can produce dangerous hyperkalemia in patients with major burns or widespread:

  1. AIron deficiency
  2. BDenervation injury
  3. CHyperthyroidism
  4. DMigraine
Show answer
Answer: B. Denervation injuryBurns and denervation up-regulate extrajunctional nicotinic receptors, allowing marked potassium release after succinylcholine.
Report a mistake

Q27. The rate-limiting enzyme in catecholamine synthesis is:

  1. AMonoamine oxidase
  2. BDopamine beta-hydroxylase
  3. CTyrosine hydroxylase
  4. DCOMT
Show answer
Answer: C. Tyrosine hydroxylaseTyrosine hydroxylase converts tyrosine to DOPA and is the rate-limiting step in catecholamine synthesis.
Report a mistake

Q28. Norepinephrine action at many sympathetic neuroeffector junctions is terminated primarily by:

  1. ABiliary excretion
  2. BAcetylcholinesterase
  3. CGlomerular filtration
  4. DNeuronal reuptake
Show answer
Answer: D. Neuronal reuptakeThe norepinephrine transporter returns released norepinephrine to presynaptic sympathetic nerve terminals and is the major termination mechanism.
Report a mistake

Q29. Alpha-1 receptor activation in vascular smooth muscle causes:

  1. AVasoconstriction
  2. BVasodilation
  3. CReduced peripheral resistance
  4. DBronchodilation
Show answer
Answer: A. VasoconstrictionAlpha-1 receptors couple to Gq and increase intracellular calcium, producing contraction of vascular smooth muscle.
Report a mistake

Q30. Presynaptic alpha-2 receptor activation generally reduces release of:

  1. AAcetylcholine at skeletal muscle
  2. BNorepinephrine
  3. CInsulin in every tissue
  4. DHistamine from mast cells only
Show answer
Answer: B. NorepinephrineAlpha-2 autoreceptors couple to Gi signaling and inhibit further norepinephrine release from sympathetic nerve terminals.
Report a mistake

Q31. Beta-1 receptor stimulation increases cardiac rate and:

  1. APupillary constriction
  2. BBronchial secretion
  3. CContractility
  4. DBladder detrusor contraction
Show answer
Answer: C. ContractilityBeta-1 receptors in the heart increase chronotropy and inotropy through Gs-mediated cAMP signaling.
Report a mistake

Q32. Beta-1 receptor activation in juxtaglomerular cells increases release of:

  1. AAtrial natriuretic peptide
  2. BAldosterone directly
  3. CADH directly
  4. DRenin
Show answer
Answer: D. ReninRenal beta-1 stimulation promotes renin secretion, activating the renin-angiotensin-aldosterone system.
Report a mistake

Q33. Beta-2 receptor stimulation in bronchial smooth muscle causes:

  1. ARelaxation
  2. BContraction
  3. CMucosal necrosis
  4. DCholinergic activation
Show answer
Answer: A. RelaxationBeta-2 receptors increase cAMP in bronchial smooth muscle and promote bronchodilation.
Report a mistake

Q34. Beta-2 receptor activation can cause skeletal muscle tremor and shift potassium:

  1. AOut of cells
  2. BInto cells
  3. CInto urine only
  4. DInto bone only
Show answer
Answer: B. Into cellsBeta-2 stimulation enhances cellular potassium uptake, which can lower serum potassium and also cause tremor.
Report a mistake

Q35. Epinephrine is the preferred first-line drug for anaphylaxis because it provides alpha-1 vasoconstriction plus beta-1 and:

  1. ADopamine blockade
  2. BMuscarinic stimulation
  3. CBeta-2 stimulation
  4. DNicotinic blockade
Show answer
Answer: C. Beta-2 stimulationEpinephrine raises vascular tone, supports cardiac output, and produces beta-2-mediated bronchodilation while reducing mediator release.
Report a mistake

Q36. Norepinephrine strongly stimulates alpha receptors and beta-1 receptors but has relatively little direct activity at:

  1. ABeta-1 receptors
  2. BAlpha-1 receptors
  3. CAlpha-2 receptors
  4. DBeta-2 receptors
Show answer
Answer: D. Beta-2 receptorsNorepinephrine is a potent alpha agonist with beta-1 activity but relatively weak beta-2 action, so vasoconstriction predominates.
Report a mistake

Q37. Phenylephrine raises vascular resistance primarily through selective stimulation of:

  1. AAlpha-1 receptors
  2. BBeta-1 receptors
  3. CBeta-2 receptors
  4. DMuscarinic M3 receptors
Show answer
Answer: A. Alpha-1 receptorsPhenylephrine is a predominantly alpha-1 agonist that causes vasoconstriction and may produce reflex bradycardia.
Report a mistake

Q38. A patient given phenylephrine may develop reflex bradycardia because the drug increases:

  1. ABronchial diameter
  2. BArterial blood pressure
  3. CInsulin secretion
  4. DSkeletal muscle contraction
Show answer
Answer: B. Arterial blood pressureAlpha-1-mediated vasoconstriction raises blood pressure, activating baroreceptor reflexes that increase vagal tone and slow heart rate.
Report a mistake

Q39. Clonidine lowers sympathetic outflow mainly by stimulating central:

  1. ABeta-1 receptors
  2. BAlpha-1 receptors
  3. CAlpha-2 receptors
  4. DNicotinic Nm receptors
Show answer
Answer: C. Alpha-2 receptorsCentral alpha-2 agonism reduces sympathetic nerve activity and can lower heart rate and vascular resistance.
Report a mistake

Q40. Albuterol relieves acute bronchospasm mainly through selective activation of:

  1. AMuscarinic M3 receptors
  2. BBeta-1 receptors
  3. CAlpha-1 receptors
  4. DBeta-2 receptors
Show answer
Answer: D. Beta-2 receptorsAlbuterol is a short-acting beta-2 agonist that relaxes bronchial smooth muscle.
Report a mistake

Q41. Dobutamine is used to increase cardiac output because it primarily stimulates:

  1. ABeta-1 receptors
  2. BAlpha-2 receptors
  3. CMuscarinic receptors
  4. DNicotinic receptors
Show answer
Answer: A. Beta-1 receptorsDobutamine has prominent beta-1 agonist activity, increasing myocardial contractility and cardiac output.
Report a mistake

Q42. Prazosin lowers blood pressure primarily by blocking vascular:

  1. AAlpha-2 receptors
  2. BAlpha-1 receptors
  3. CBeta-1 receptors
  4. DM2 receptors
Show answer
Answer: B. Alpha-1 receptorsSelective alpha-1 blockade relaxes arteriolar and venous smooth muscle, reducing peripheral resistance and venous return.
Report a mistake

Q43. A notable adverse effect after the first dose of prazosin is:

  1. AHyperkalemia in every patient
  2. BSevere bronchospasm
  3. COrthostatic hypotension
  4. DMiosis
Show answer
Answer: C. Orthostatic hypotensionAlpha-1 blockade can cause marked postural hypotension and syncope, particularly after the first dose.
Report a mistake

Q44. Tamsulosin improves urinary flow in benign prostatic hyperplasia mainly by blocking alpha-1 receptors in the prostate and:

  1. AUreteral epithelium
  2. BDetrusor parasympathetic nerves
  3. CRenal glomerulus
  4. DBladder neck
Show answer
Answer: D. Bladder neckSelective alpha-1A blockade relaxes smooth muscle in the prostate and bladder neck, reducing dynamic urinary obstruction.
Report a mistake

Q45. Phenoxybenzamine is useful before surgery for pheochromocytoma because it produces long-lasting:

  1. AAlpha-adrenergic blockade
  2. BBeta-2 stimulation
  3. CMuscarinic blockade
  4. DDopamine synthesis inhibition
Show answer
Answer: A. Alpha-adrenergic blockadePhenoxybenzamine irreversibly blocks alpha receptors, reducing catecholamine-mediated vasoconstriction before tumor manipulation.
Report a mistake

Q46. Propranolol blocks both beta-1 and:

  1. AAlpha-1 receptors
  2. BBeta-2 receptors
  3. CAlpha-2 receptors
  4. DMuscarinic M2 receptors
Show answer
Answer: B. Beta-2 receptorsPropranolol is a nonselective beta antagonist that blocks both beta-1 and beta-2 adrenergic receptors.
Report a mistake

Q47. Metoprolol is relatively selective for which receptor at usual therapeutic doses?

  1. AAlpha-1
  2. BBeta-2
  3. CBeta-1
  4. DAlpha-2
Show answer
Answer: C. Beta-1Metoprolol preferentially blocks beta-1 receptors, although selectivity diminishes as the dose increases.
Report a mistake

Q48. Nonselective beta blockers can worsen asthma because blockade of beta-2 receptors promotes:

  1. APulmonary vasodilation only
  2. BBronchodilation
  3. CReduced airway secretions only
  4. DBronchoconstriction
Show answer
Answer: D. BronchoconstrictionBlocking beta-2-mediated bronchial relaxation can increase airway resistance in susceptible patients.
Report a mistake

Q49. Beta blockers reduce renin release primarily by blocking beta-1 receptors on:

  1. AJuxtaglomerular cells
  2. BAdrenal cortical cells
  3. CHepatocytes
  4. DPlatelets
Show answer
Answer: A. Juxtaglomerular cellsBeta-1 blockade in the kidney suppresses renin release and contributes to the antihypertensive effect of beta blockers.
Report a mistake

Q50. Abrupt withdrawal of long-term beta-blocker therapy may cause rebound tachycardia because chronic blockade can lead to receptor:

  1. ADown-regulation
  2. BUp-regulation
  3. CIrreversible destruction
  4. DDesensitization only
Show answer
Answer: B. Up-regulationLong-term antagonism can increase beta-receptor responsiveness or number, making abrupt withdrawal capable of producing exaggerated sympathetic effects.
Report a mistake

Q51. Labetalol lowers blood pressure through blockade of beta receptors and:

  1. ANicotinic receptors
  2. BMuscarinic receptors
  3. CAlpha-1 receptors
  4. DDopamine D2 receptors
Show answer
Answer: C. Alpha-1 receptorsLabetalol combines beta blockade with alpha-1 antagonism, reducing vascular resistance while limiting reflex cardiac stimulation.
Report a mistake

Q52. Which autonomic drug class is most likely to cause urinary retention, dry mouth, blurred vision, and tachycardia?

  1. AAcetylcholinesterase inhibitors
  2. BMuscarinic agonists
  3. CBeta-2 agonists only
  4. DMuscarinic antagonists
Show answer
Answer: D. Muscarinic antagonistsThis cluster reflects reduced parasympathetic muscarinic activity in the bladder, glands, eye, and heart.
Report a mistake

Q53. A patient with pinpoint pupils, salivation, diarrhea, wheezing, and bradycardia most likely has excessive stimulation of:

  1. AMuscarinic receptors
  2. BBeta-1 receptors
  3. CAlpha-1 receptors
  4. DDopamine receptors
Show answer
Answer: A. Muscarinic receptorsMiosis, secretions, bronchoconstriction, increased gastrointestinal activity, and bradycardia are classic manifestations of muscarinic excess.
Report a mistake

Q54. A drug that selectively blocks beta-1 receptors would be expected to reduce heart rate while having less direct effect on:

  1. ASA nodal activity
  2. BBronchial smooth muscle
  3. CRenin release
  4. DMyocardial contractility
Show answer
Answer: B. Bronchial smooth muscleBronchial relaxation is mediated mainly by beta-2 receptors, so beta-1-selective blockade has less direct bronchial effect at usual doses.
Report a mistake

Q55. Which pairing is pharmacologically correct?

  1. APhenylephrine — alpha-1 antagonist
  2. BNeostigmine — beta-2 agonist
  3. CAtropine — muscarinic antagonist
  4. DPropranolol — muscarinic agonist
Show answer
Answer: C. Atropine — muscarinic antagonistAtropine competitively antagonizes muscarinic acetylcholine receptors; the other listed drug-receptor pairings are incorrect.
Report a mistake